332 related articles for article (PubMed ID: 10470987)
1. Effects of a DA2/alpha2 agonist and a beta1-blocker in combination with an ACE inhibitor on adrenergic activity and left ventricular remodeling in an experimental model of left ventricular dysfunction after coronary artery occlusion.
Masson S; Masseroli M; Fiordaliso F; Calvillo L; D'Aquila S; Bernasconi R; Garrido G; Torri M; Razzetti R; Bongrani S; Latini R
J Cardiovasc Pharmacol; 1999 Sep; 34(3):321-6. PubMed ID: 10470987
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of a DA2/alpha2 agonist and a beta-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion.
Latini R; Masson S; Jeremic G; Luvarà G; Fiordaliso F; Calvillo L; Bernasconi R; Torri M; Rondelli I; Razzetti R; Bongrani S
J Cardiovasc Pharmacol; 1998 Apr; 31(4):601-8. PubMed ID: 9554811
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor.
Ahmet I; Morrell C; Lakatta EG; Talan MI
J Pharmacol Exp Ther; 2009 Oct; 331(1):178-85. PubMed ID: 19587314
[TBL] [Abstract][Full Text] [Related]
4. CHF-1024, a DA2/alpha2 agonist, blunts norepinephrine excretion and cardiac fibrosis in pressure overload.
Masson S; Chimenti S; Salio M; Torri M; Limana F; Bernasconi R; Calvillo L; Santambrogio D; Gagliano N; Arosio B; Annoni G; Razzetti R; Bongrani S; Latini R
Cardiovasc Drugs Ther; 2001 Mar; 15(2):131-8. PubMed ID: 11669406
[TBL] [Abstract][Full Text] [Related]
5. Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure.
Omerovic E; Bollano E; Soussi B; Waagstein F
Eur J Heart Fail; 2003 Dec; 5(6):725-32. PubMed ID: 14675850
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
Tao ZW; Huang YW; Xia Q; Xu QW
Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801
[TBL] [Abstract][Full Text] [Related]
7. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction.
Fraccarollo D; Galuppo P; Hildemann S; Christ M; Ertl G; Bauersachs J
J Am Coll Cardiol; 2003 Nov; 42(9):1666-73. PubMed ID: 14607457
[TBL] [Abstract][Full Text] [Related]
8. Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Effects on survival, hemodynamics, and cardiovascular remodeling.
Mulder P; Devaux B; Richard V; Henry JP; Wimart MC; Thibout E; Macé B; Thuillez C
Circulation; 1997 Mar; 95(5):1314-9. PubMed ID: 9054865
[TBL] [Abstract][Full Text] [Related]
9. Myocardial effects of beta-agonist stimulation in rats with chronic left ventricular dysfunction treated with an angiotensin-converting enzyme inhibitor.
Cherng WJ; Wang CH; Chen SF; Hung MJ
Changgeng Yi Xue Za Zhi; 1999 Dec; 22(4):546-55. PubMed ID: 10695200
[TBL] [Abstract][Full Text] [Related]
10. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
Yaoita H; Sakabe A; Maehara K; Maruyama Y
Circulation; 2002 Feb; 105(8):975-80. PubMed ID: 11864928
[TBL] [Abstract][Full Text] [Related]
11. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study.
Circulation; 2000 Feb; 101(4):378-84. PubMed ID: 10653828
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with angiotensin I-converting enzyme inhibitors attenuates the loss of cardiac beta-adrenoceptor responses in rats with chronic heart failure.
Sanbe A; Takeo S
Circulation; 1995 Nov; 92(9):2666-75. PubMed ID: 7586371
[TBL] [Abstract][Full Text] [Related]
13. Effects of the angiotensin-converting enzyme inhibitor enalapril on sympathetic neuronal function and beta-adrenergic desensitization in heart failure after myocardial infarction in rats.
Igawa A; Nozawa T; Yoshida N; Fujii N; Kato B; Inoue M; Tazawa S; Yamada Y; Asanoi H; Inoue H
Jpn Heart J; 2002 Nov; 43(6):675-88. PubMed ID: 12558131
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
Shinohara H; Fukuda N; Soeki T; Sakabe K; Onose Y; Tamura Y
Heart Vessels; 2002 Dec; 17(2):47-52. PubMed ID: 12541093
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival and hemodynamics after endothelin-a receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: monotherapy versus combination therapy.
Mulder P; Boujedaini H; Richard V; Henry JP; Renet S; Münter K; Thuillez C
Circulation; 2002 Aug; 106(9):1159-64. PubMed ID: 12196345
[TBL] [Abstract][Full Text] [Related]
16. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy.
Ahmet I; Lakatta EG; Talan MI
Heart Fail Rev; 2005 Dec; 10(4):289-96. PubMed ID: 16583177
[TBL] [Abstract][Full Text] [Related]
18. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction.
Wei S; Chow LT; Sanderson JE
J Am Coll Cardiol; 2000 Jul; 36(1):276-81. PubMed ID: 10898446
[TBL] [Abstract][Full Text] [Related]
19. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)].
Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
Ter Arkh; 2006; 78(8):14-20. PubMed ID: 17078211
[TBL] [Abstract][Full Text] [Related]
20. Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.
van Veldhuisen DJ; Brodde OE; van Gilst WH; Schulze C; Hegeman H; Anthonio RL; Scholtens E; de Graeff PA; Wesseling H; Lie KI
Cardiovasc Res; 1995 Sep; 30(3):386-93. PubMed ID: 7585830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
